rs12048215

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001243133.2(NLRP3):​c.278-1941A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.114 in 151,924 control chromosomes in the GnomAD database, including 1,172 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1172 hom., cov: 32)

Consequence

NLRP3
NM_001243133.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0880

Publications

11 publications found
Variant links:
Genes affected
NLRP3 (HGNC:16400): (NLR family pyrin domain containing 3) This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NLRP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. The SARS-CoV 3a protein, a transmembrane pore-forming viroporin, has been shown to activate the NLRP3 inflammasome via the formation of ion channels in macrophages. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, neonatal-onset multisystem inflammatory disease (NOMID), keratoendotheliitis fugax hereditarian, and deafness, autosomal dominant 34, with or without inflammation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Alternative 5' UTR structures are suggested by available data; however, insufficient evidence is available to determine if all of the represented 5' UTR splice patterns are biologically valid. [provided by RefSeq, Aug 2020]
NLRP3 Gene-Disease associations (from GenCC):
  • CINCA syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • cryopyrin-associated periodic syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina
  • familial cold autoinflammatory syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • familial cold autoinflammatory syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • Muckle-Wells syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • keratitis fugax hereditaria
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.283 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NLRP3NM_001243133.2 linkc.278-1941A>G intron_variant Intron 2 of 9 ENST00000336119.8 NP_001230062.1 Q96P20A0A7I2R3P8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NLRP3ENST00000336119.8 linkc.278-1941A>G intron_variant Intron 2 of 9 1 NM_001243133.2 ENSP00000337383.4 A0A7I2R3P8

Frequencies

GnomAD3 genomes
AF:
0.114
AC:
17317
AN:
151806
Hom.:
1162
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0587
Gnomad AMI
AF:
0.0839
Gnomad AMR
AF:
0.166
Gnomad ASJ
AF:
0.136
Gnomad EAS
AF:
0.296
Gnomad SAS
AF:
0.165
Gnomad FIN
AF:
0.132
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.116
Gnomad OTH
AF:
0.103
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.114
AC:
17344
AN:
151924
Hom.:
1172
Cov.:
32
AF XY:
0.116
AC XY:
8619
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.0586
AC:
2428
AN:
41438
American (AMR)
AF:
0.168
AC:
2558
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.136
AC:
472
AN:
3468
East Asian (EAS)
AF:
0.296
AC:
1515
AN:
5122
South Asian (SAS)
AF:
0.165
AC:
794
AN:
4812
European-Finnish (FIN)
AF:
0.132
AC:
1395
AN:
10560
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.116
AC:
7872
AN:
67954
Other (OTH)
AF:
0.107
AC:
226
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
756
1511
2267
3022
3778
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.120
Hom.:
876
Bravo
AF:
0.114
Asia WGS
AF:
0.244
AC:
848
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.0
DANN
Benign
0.84
PhyloP100
-0.088
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12048215; hg19: chr1-247584591; API